|
Dbv Technologies S a (NASDAQ: DBVT) |
|
Dbv Technologies S a
DBVT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Dbv Technologies S A 's sales fell
by -54.81 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1690
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.31 %
Dbv Technologies S A net loss increased from $-17 millions, to $-30 millions in III. Quarter 2024,
• More on DBVT's Growth
|
|
Dbv Technologies S A realized a net loss in trailing twelve months.
Dbv Technologies S A realized cash reduction of $ -6.4 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 5.56.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.57.
• More on DBVT's Valuation
|
|
|
|
|
Dbv Technologies S A realized net loss in trailing twelve months.
Dbv Technologies S A realized cash outflow of $ -6.4per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 5.56.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.57.
Dbv Technologies S A Price to Book Ratio is at 1.29 lower than Industry Avg. of 476.72. and higher than S&P 500 Avg. of 0.01
• More on DBVT's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com